Ra Medical Systems announced that VIVO, the lead product for the electrophysiology division, has been used in more than 1000 ventricular ablation procedures. VIVO, which stands for View Into Ventricular Onset, enables physicians to learn more about patient specific anatomy and better help them plan the ablation procedure. As a result, VIVO aids in reducing overall procedure time benefitting physicians, hospitals and patients.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RMED:
- Ra Medical Systems announces proposed name, ticker symbol change
- Ra Medical Systems sees increase in clinical adoption of VIVO System
- Ra Medical Systems says LockeT device utilized in structural heart procedures
- Ra Medical Systems’ electrophysiology division expands international distributon
- Ra Medical’s Catheter Precision submits data for CE Mark on LockeT product
